title: Different answer to recombinant human erythropoietin in anephric and non-anephric haemodialyzed patients.
authors.forename: M
authors.initials: M
authors.lastname: Buemi
authors.forename: A
authors.initials: A
authors.lastname: Allegra
authors.forename: C
authors.initials: C
authors.lastname: Aloisi
authors.forename: M S
authors.initials: MS
authors.lastname: Giacobbe
authors.forename: N
authors.initials: N
authors.lastname: Frisina
mesh_terms: D000328:Adult; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D006435:Renal Dialysis; D013927:Thrombosis / Q000139:chemically induced
chemical_list: D004921:Erythropoietin